| CAT No: | CL-CZT-02 |
| CAS No: | NA |
| Mol.F: | C25H30Cl2FN5O2 |
| Mol.Wt.: | 522.4 |
| Rel. Cas No: | |
| Chemical Name: | (R)-4-(4-(4-(6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidin-1-yl)butan-1-ol |
| SMILES: | C[C@@H](Oc1cc(cnc1N)c2cnn(c2)C3CCN(CCCCO)CC3)c4c(Cl)ccc(F)c4Cl |
| Inventory Status: | Custom synthesis |
This impurity is related to Crizotinib Impurity 1 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Crizotinib Impurity 1 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(R)-4-(4-(4-(6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidin-1-yl)butan-1-olCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Crizotinib Molecular Formula: C25H30Cl2FN5O2
Molecular Weight: 522.4
Storage: Store in a cool, dry place.
| Product Name: | Crizotinib Impurity 1 |
| CAS No: | |
| Mol.F.: | C25H30Cl2FN5O2 |
| Mol.Wt.: | 522.4 |
-Crizotinib-D5.jpg)
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: